Xiaobin Wu, President, COO & GM China at BeiGene, Ltd. (BGNE), sold 103,842 shares at $280.31 ($29.2M) on 2025-04-01, disclosed to the SEC on 2025-04-03.
Scheduled sale ($29.2M) by President, COO & GM China under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $280.31 | 28,253 | $7.9M | 27.1% |
| 2 | $280.31 | 28,253 | $7.9M | 27.1% |
| 3 | $281.67 | 6,364 | $1.8M | 6.1% |
| 4 | $281.67 | 6,364 | $1.8M | 6.1% |
| 5 | $282.76 | 12,221 | $3.5M | 11.8% |
| 6 | $282.76 | 12,221 |
| $3.5M |
| 11.8% |
| 7 | $283.79 | 5,083 | $1.4M | 4.9% |
| 8 | $283.79 | 5,083 | $1.4M | 4.9% |
| Total | $281.39 avg | 103,842 | $29.2M | 100% |
| Filing → |
| ONC | SELL | 2026-06-18 | $362K | — | Filing → |
| ONC | SELL | 2026-06-15 | $164K | — | Filing → |
| ONC | SELL | 2026-06-10 | $400K | — | Filing → |